The Disease Susceptibility Genetic Test-Obesity
The Disease Susceptibility Genetic Test-Obesity
According to the test results, provide personalized dietary advice, exercise, and weight loss suggestions to achieve the purpose of effective prevention of obesity and scientific weight loss.
Test Content of the Disease Susceptibility Obesity Genetic Test-Obesity
Obesity genetic risk assessment.
The effect of the three major nutrients carbohydrates, lipids and protein on body weight.
Weight loss effect of aerobic exercise, strength training and other exercise methods.
Applicable Population of the Disease Susceptibility Genetic Test-Obesity
People with unhealthy eating habits;
People who live irregularly, suffer from long-term insomnia or stay up late;
People who lack exercise or physical activity;
Those whose mothers have suffered from gestational diabetes or postpartum obesity;
People with high birth weight (≥ 4 kg) or low weight (≤ 2.5 kg) at birth;
People who have been identified as overweight or obese according to evaluation criteria such as BMI;
People who have no obvious weight loss effect through diet and exercise;
Those who want to know whether they are susceptible to obesity;
Those who need weight management;
People with a family history of obesity.
Specification of the Disease Susceptibility Genetic Test-Obesity
|
Sample types |
Venous blood / Oral swab |
|
TAT |
9 working days |
CapitalBioTechnology Co., Ltd. (abbreviated “CapitalBio”) is the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. CapitalBio has always adhered to independent innovation and achievement transformation and has a complete industrial chain integrating R&D, production, sales, and thrid-party independent medical laboratory services; and responds to the national policy of “prevention first.” The health policy integrates modern medicine and traditional Chinese medicine to form a large health industry section that includes health products, health management, medical rehabilitation, and big data.
As one of dna sequencing companies, we will do our best to meet all the needs of customers.
Send product request
Other supplier products
 |
Clinical WES | At present, there are more than 20,000 human genes have been discovered, with a total of more than 180,000 exons. Genes are composed of exons and i... |
 |
Metabolic Testing-Food Intolerance (101 Items) | Metabolic Testing-Food Intolerance (101 Items) Food intolerance test qataris suitable for 9 common recipe categories (egg and milk, grain and nuts... |
 |
CapitalBio® Microarray Hybridization Station | The CapitalBio® BioMixerTMII is a microarray hybridization stationthat uses continuous 3-D motion to help the aqueous hybridization mixture spr... |
 |
Individualized Medication Guidance for Cancer (118 Genes) | This cancer genetic testdetects 136 genes, including 110 targeted drug-related genes and 27 chemotherapy drug-related genes, provides the correlati... |
 |
CapitalBio® DNA Microarray Scanner LuxScan™10K | The CapitalBio LuxScan™ 10K microarray gene array scanner is a compact high performance system for microarray imaging and the analysis of DNA... |
